Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Taurine and Reduced Interleukin-6 Levels

Doses used in studies

mg/day: 3,000 (median 3,000, IQR 3,000–3,000) — 1 study

Safety in these studies

Overall tolerabilityReported
a daily dose of 3,000 mg appears to offer an optimal balance between clinical efficacy and tolerability
from: Taurine supplementation as a therapeutic strategy for cellular senescence and chronic infl

2 of 2 papers

Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysis.
- 2026-03-10
- Meta-Analysis · n = 308
- BMC infectious diseases 26(1)
- - Kaiming Wang
  - Chen Hsiang Ma
  - Mobin Khoramjoo
  - Janice Y Kung
  - Gavin Y Oudit
- PubMed: 41803812
- DOI: 10.1186/s12879-026-13009-y
16 Insights on
- Reduced Interleukin-6 Levels
- High evidence
- Clinical
Analysis of 27 clinical trials (n = 1,030) demonstrated that taurine supplementation significantly improved markers of ... inflammation (C-reactive protein, TNF-⍺, and IL-6)
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
3000 mg/day
Efficacy of taurine-enhanced enteral nutrition in improving the outcomes of critically ill patients: A systematic review and meta-analysis.
- 2024-06
- Meta-Analysis · n = 236
- Clinical nutrition ESPEN 61
- - Chi Zhang
  - Ming-Wei Sun
  - Guang-Yu Yang
  - Yu Wang
  - Charles Damien Lu
  - Hua Jiang
- PubMed: 38777434
- DOI: 10.1016/j.clnesp.2024.03.012
4 Insights on
- Reduced Interleukin-6 Levels
- High evidence
- Clinical
Taurine-enhanced EN may reduce pro-inflammatory factor interleukin-6 (IL-6) levels in critically ill patients（the result about IL-6 cannot be pooled）.
Effect
Neutral
Effect size
Small